Kapat
Popüler Videolar
Moods
Türler
English
Türkçe
Popüler Videolar
Moods
Türler
Turkish
English
Türkçe
Investigating the Use of Fostamatinib in ITP
9:47
|
Loading...
Download
Lütfen bekleyiniz...
Type
Size
İlgili Videolar
Investigating the Use of Fostamatinib in ITP
9:47
|
Dr. Fertrin on the Potential of Fostamatinib in Chronic ITP
1:24
|
Fostamatinib and efgartigimod: novel agents in the treatment of ITP
1:54
|
Fostamatinib as Second-Line ITP Therapy
10:12
|
Michael Boxer, MD, on the effectiveness of fostamatinib in the maintenance of ITP responses
2:49
|
Potential Role of Syk Inhibitors in ITP
3:09
|
A Case of Immune Thrombocytopenia
3:55
|
Risks With Untreated ITP
3:39
|
First-Line Therapy Options for Patients with ITP
5:15
|
ITP: Second-Line Therapy
2:26
|
Immune Thrombocytopenia: Impact of the EXTEND Trial
4:20
|
Choosing New Agents for ITP
2:04
|
Presenting With Immune Thrombocytopenia
4:07
|
Treating Persistent/Chronic ITP Current Care, Future Potential
45:50
|
Duration of Platelet Recovery With TPO-RAs
2:10
|
Haematology - ITP (immune thrombocytopenic purpura)
22:03
|
Dr.Gobind Rai Garg discusses the topic - Fostamatinib
2:18
|
Treating Refractory Idiopathic Thrombocytopenic Purpura (ITP)
5:34
|
Michael Boxer, MD, considers broader uses for fostamatinib
1:09
|
ITP Patient Management and Important Treatment Factors
2:38
|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa
